Literature DB >> 26526106

Making a Hematopoietic Stem Cell.

Michael G Daniel1, Carlos-Filipe Pereira2, Ihor R Lemischka3, Kateri A Moore4.   

Abstract

Previous attempts to either generate or expand hematopoietic stem cells (HSCs) in vitro have involved either ex vivo expansion of pre-existing patient or donor HSCs or de novo generation from pluripotent stem cells (PSCs), comprising both embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs). iPSCs alleviated ESC ethical issues but attempts to generate functional mature hematopoietic stem and progenitor cells (HSPCs) have been largely unsuccessful. New efforts focus on directly reprogramming somatic cells into definitive HSCs and HSPCs. To meet clinical needs and to advance drug discovery and stem cell therapy, alternative approaches are necessary. In this review, we synthesize the strategies used and the key findings made in recent years by those trying to make an HSC. Published by Elsevier Ltd.

Entities:  

Keywords:  hematopoiesis; hematopoietic stem cell; reprogramming; transcription factors

Mesh:

Year:  2015        PMID: 26526106      PMCID: PMC4764442          DOI: 10.1016/j.tcb.2015.10.002

Source DB:  PubMed          Journal:  Trends Cell Biol        ISSN: 0962-8924            Impact factor:   20.808


  89 in total

1.  Development of a vascular niche platform for expansion of repopulating human cord blood stem and progenitor cells.

Authors:  Jason M Butler; Eric J Gars; Daylon J James; Daniel J Nolan; Joseph M Scandura; Shahin Rafii
Journal:  Blood       Date:  2012-06-18       Impact factor: 22.113

2.  Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells.

Authors:  Anthony E Boitano; Jian Wang; Russell Romeo; Laure C Bouchez; Albert E Parker; Sue E Sutton; John R Walker; Colin A Flaveny; Gary H Perdew; Michael S Denison; Peter G Schultz; Michael P Cooke
Journal:  Science       Date:  2010-08-05       Impact factor: 47.728

3.  Embryonic stem cell-derived hematopoietic stem cells.

Authors:  Yuan Wang; Frank Yates; Olaia Naveiras; Patricia Ernst; George Q Daley
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-15       Impact factor: 11.205

4.  SCL/TAL1 regulates hematopoietic specification from human embryonic stem cells.

Authors:  Pedro J Real; Gertrudis Ligero; Veronica Ayllon; Veronica Ramos-Mejia; Clara Bueno; Ivan Gutierrez-Aranda; Oscar Navarro-Montero; Majlinda Lako; Pablo Menendez
Journal:  Mol Ther       Date:  2012-04-10       Impact factor: 11.454

5.  In vivo generation of transplantable human hematopoietic cells from induced pluripotent stem cells.

Authors:  Giovanni Amabile; Robert S Welner; Cesar Nombela-Arrieta; Anna Morena D'Alise; Annalisa Di Ruscio; Alexander K Ebralidze; Yevgenya Kraytsberg; Min Ye; Olivier Kocher; Donna S Neuberg; Konstantin Khrapko; Leslie E Silberstein; Daniel G Tenen
Journal:  Blood       Date:  2012-12-04       Impact factor: 22.113

6.  Conversion of human fibroblasts into monocyte-like progenitor cells.

Authors:  Julian Pulecio; Emmanuel Nivet; Ignacio Sancho-Martinez; Marianna Vitaloni; Guillermo Guenechea; Yun Xia; Leo Kurian; Ilir Dubova; Juan Bueren; Leopoldo Laricchia-Robbio; Juan Carlos Izpisua Belmonte
Journal:  Stem Cells       Date:  2014-11       Impact factor: 6.277

7.  Direct reprogramming of fibroblasts into embryonic Sertoli-like cells by defined factors.

Authors:  Yosef Buganim; Elena Itskovich; Yueh-Chiang Hu; Albert W Cheng; Kibibi Ganz; Sovan Sarkar; Dongdong Fu; G Grant Welstead; David C Page; Rudolf Jaenisch
Journal:  Cell Stem Cell       Date:  2012-09-07       Impact factor: 24.633

Review 8.  Hematopoietic cell differentiation from embryonic and induced pluripotent stem cells.

Authors:  Wai Feng Lim; Tomoko Inoue-Yokoo; Keai Sinn Tan; Mei I Lai; Daisuke Sugiyama
Journal:  Stem Cell Res Ther       Date:  2013-06-18       Impact factor: 6.832

9.  An expandable, inducible hemangioblast state regulated by fibroblast growth factor.

Authors:  David T Vereide; Vernella Vickerman; Scott A Swanson; Li-Fang Chu; Brian E McIntosh; James A Thomson
Journal:  Stem Cell Reports       Date:  2014-11-13       Impact factor: 7.765

10.  Runx1 is required for the endothelial to haematopoietic cell transition but not thereafter.

Authors:  Michael J Chen; Tomomasa Yokomizo; Brandon M Zeigler; Elaine Dzierzak; Nancy A Speck
Journal:  Nature       Date:  2009-01-07       Impact factor: 49.962

View more
  22 in total

1.  Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic coculture.

Authors:  Michael G Daniel; David Sachs; Jeffrey M Bernitz; Yesai Fstkchyan; Katrina Rapp; Namita Satija; Kenneth Law; Foram Patel; Andreia M Gomes; Huen-Suk Kim; Carlos-Filipe Pereira; Benjamin Chen; Ihor R Lemischka; Kateri A Moore
Journal:  FEBS Lett       Date:  2019-10-12       Impact factor: 4.124

Review 2.  Of Cytometry, Stem Cells and Fountain of Youth.

Authors:  Dariusz Galkowski; Mariusz Z Ratajczak; Janusz Kocki; Zbigniew Darzynkiewicz
Journal:  Stem Cell Rev Rep       Date:  2017-08       Impact factor: 5.739

Review 3.  Progress towards generation of human haematopoietic stem cells.

Authors:  Lara Wahlster; George Q Daley
Journal:  Nat Cell Biol       Date:  2016-10-10       Impact factor: 28.824

4.  Reprogramming Mouse Embryonic Fibroblasts with Transcription Factors to Induce a Hemogenic Program.

Authors:  Michael G Daniel; Carlos-Filipe Pereira; Jeffrey M Bernitz; Ihor R Lemischka; Kateri Moore
Journal:  J Vis Exp       Date:  2016-12-16       Impact factor: 1.355

5.  Emergence of CD43-Expressing Hematopoietic Progenitors from Human Induced Pluripotent Stem Cells.

Authors:  Katharina U Kessel; Anika Bluemke; Hans R Schöler; Holm Zaehres; Peter Schlenke; Isabel Dorn
Journal:  Transfus Med Hemother       Date:  2017-05-29       Impact factor: 3.747

Review 6.  Emerging cellular and gene therapies for congenital anemias.

Authors:  Leif S Ludwig; Rajiv K Khajuria; Vijay G Sankaran
Journal:  Am J Med Genet C Semin Med Genet       Date:  2016-10-28       Impact factor: 3.908

7.  Vitamin C-dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transition.

Authors:  Tian Zhang; Ke Huang; Yanling Zhu; Tianyu Wang; Yongli Shan; Bing Long; Yuhang Li; Qianyu Chen; Pengtao Wang; Shaoyang Zhao; Dongwei Li; Chuman Wu; Baoqiang Kang; Jiaming Gu; Yuchan Mai; Qing Wang; Jinbing Li; Yanqi Zhang; Zechuan Liang; Lin Guo; Fang Wu; Shuquan Su; Junwei Wang; Minghui Gao; Xiaofen Zhong; Baojian Liao; Jiekai Chen; Xiao Zhang; Xiaodong Shu; Duanqing Pei; Jinfu Nie; Guangjin Pan
Journal:  J Biol Chem       Date:  2019-07-24       Impact factor: 5.157

8.  Mitochondrial inhibitors circumvent adaptive resistance to venetoclax and cytarabine combination therapy in acute myeloid leukemia.

Authors:  Lucille Stuani; Carine Joffre; Claudie Bosc; Estelle Saland; Aurélie Bousard; Noémie Gadaud; Marie Sabatier; Guillaume Cognet; Thomas Farge; Emeline Boet; Mathilde Gotanègre; Nesrine Aroua; Pierre-Luc Mouchel; Nathaniel Polley; Clément Larrue; Eléonore Kaphan; Muriel Picard; Ambrine Sahal; Latifa Jarrou; Marie Tosolini; Florian Rambow; Florence Cabon; Nathalie Nicot; Laura Poillet-Perez; Yujue Wang; Xiaoyang Su; Quentin Fovez; Jérôme Kluza; Rafael José Argüello; Céline Mazzotti; Hervé Avet-Loiseau; François Vergez; Jérôme Tamburini; Jean-Jacques Fournié; Ing S Tiong; Andrew H Wei; Tony Kaoma; Jean-Christophe Marine; Christian Récher; Jean-Emmanuel Sarry
Journal:  Nat Cancer       Date:  2021-11-11

Review 9.  Applications of stem cell biology to oculoplastic surgery.

Authors:  Michael G Daniel; Albert Y Wu
Journal:  Curr Opin Ophthalmol       Date:  2016-09       Impact factor: 3.761

10.  Metabolic Regulation of Inflammasome Activity Controls Embryonic Hematopoietic Stem and Progenitor Cell Production.

Authors:  Jenna M Frame; Caroline Kubaczka; Timothy L Long; Virginie Esain; Rebecca A Soto; Mariam Hachimi; Ran Jing; Arkadi Shwartz; Wolfram Goessling; George Q Daley; Trista E North
Journal:  Dev Cell       Date:  2020-08-17       Impact factor: 12.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.